Healthcare Professionals and Patient Perceptions on the Use of Herbal Medicines to Control Diabetes Mellitus and Hypertension in Nigeria

Nwankwo Ogechukwu  Lucy; Ogbonna Brian  Onyebuchi

doi:10.47540/ijias.v3i2.752

Authors

Nwankwo Ogecchukwu L. Department of Pharmacognosy and Traditional Medicine, Nnamdi Azikiwe University, Nigeria
Ogbonna Brian Onyebuchi Department of Clinical Pharmacy and Pharmacy Management, Nnamdi Azikiwe University, Nigeria

DOI:

https://doi.org/10.47540/ijias.v3i2.752

Keywords:

Diabetes Mellitus, Disease Control, Herbal Medicine, Hypertension, Medicinal Plants

Abstract

The perception that herbal medicines are generally safe and non-toxic, has all necessitated patients' use of herbs in the management of diabetes and hypertension. The study evaluated healthcare professionals' and patients' perceptions of the use of herbs to control diabetes mellitus (DM) and hypertension. The study utilized a randomized sampling method for the survey; an online form was designed and used for data collection. The questionnaire was sent to professional and non-professional groups having the target population (patients and relatives. The results showed that the majority of the participants stated the use of Vernonia amagdalena in the management of HTN (33.0%) and DM (9.9%). Other plants mentioned include Moringa leaves HTN n (5.5%), DM n(6.6%); Carica papaya; HTN (9.9%), DM (8.2); Ginger, and DM (12.6%). Dogoyaro/Agbo (4.9%). Notable antidiabetic plants reported in this study include Rauwolfia vomitoria (1.1%), Ugu leaves (2.2%), Hibiscus (zobo) (4.4%), Ocimum gratiscimum (1.1%), cucumber (1.1%), neem plant (3.8%). Previous knowledge on Diabetes Mellitus between the patients and healthcare workers was P=0.038 while previous knowledge on hypertension was p=0.029. The knowledge of herbal product(s) used in diabetes was p=0.043 while knowledge of herbal product(s) used in hypertension was p=0.019, at p<0.05. It was thus concluded that the participants believe that herbal medicines can relieve disease within a short period, are effective at the correct dosage, have fewer side effects or no side effects at the proper doses, and can effect a complete cure if standardized, affordable, better tolerated in the body.

References

Ahmed D, Sharma M, Mukerjee A, Ramteke PW, Kumar V, (2013). Improved glycemic control, pancreas protective, and hepatoprotective effect by the traditional polyherbal formulation “Qurs Tabasheer” in streptozotocin-induced diabetic rats. BMC Complementary Alternative Medicine, (13), 10.

Aja P M, Nwachukwu N, Ibiam U A, Igwenyi I O, Offor C E, Orji U O (2014). Chemical Constituents of Moringa Oleifera leaves and Seeds from Abakaliki Nigeria. America Journal of Phytomedicine and Clinical Therapeutics, 2(3), 310–321.

Alter JS, Nair RM, Nair R. (2017). Nature Cure and Non-Communicable Diseases: Ecological Therapy as Health Care in India. International Journal of Environmental Research and Public Health, 14(12), 1525.

Ampa LK, Tanaree J. (2013). Antihyperglycaemic properties of Moringa oleiferaLam. Aqueous leaf extract in normal and mildly diabetic mice. British Journal of Pharmacology and Toxicology, 4(3), 106–109.

Andrew K. Tusubira, Ann R. Akiteng, Brenda D. Nakirya, Ritah Nalwoga, Isaac Ssinabulya, Christine K. Nalwadda, and Jeremy I. Schwartz, (2020). Accessing medicines for non-communicable diseases: Patients and health care workers’ experiences at public and private health facilities in Uganda. PLoS ONE, 15(7), e0235696.

Anuradha CV (2013). Phytochemicals targeting genes relevant for type 2 diabetes. Journal of Physiology and Pharmacology, (6), 397-411.

Aravind G, DebjitBhowmik D, Harish G., (2013). Traditional and Medicinal uses of Carica papaya. Journal of Medicinal Plants Studies, 1(1), 7–15.

Edoga CO, Njokwu O, Amadi EN, Okeke J (2013). Blood sugar lowering effect on Moringa oleifera Lam in albino rats. International Journal of Science and Technology, 3(1), 88–90.

Ezekwe, AS, Elekwa, I., Osuocha, K. (2014). Hypoglycaemic, hypolipidemic, and body weight effect of the unripe pulp of Carica papaya using diabetic Albino rat model. Journal of Pharmacognosy and Phytochemistry, 2(6), 109-114.

Gezawa ID, Puepet FH, Mubi BM, Uloko AE, Haliru I. (2013). Prevalence of overweight and obesity in Maiduguri North-Eastern Nigeria. Nigerian J Med, 22(3),171–174.

Ghada ZA., (2013). Antidiabetic activity of dried Moringa oleifera leaves in normal and streptozotocin-induced diabetic male rats. India Journal of Applied Research, 3(9), 18–23.

Global Burden of Disease Study (GBD), (2015). Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388 (10053), 1659-1724.

Hashmi, M. A., Khan, A., Hanif, M., Farooq, U., & Perveen, S. (2015). Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive). Evidence-based complementary and alternative medicine: eCAM, 541591.

James BI, Wardle J, Steel A, Adams J. (2018). Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Glob Health, (3), e000895.

Judith Marcin and Erica Cirino (2018). Most Common Non-communicable Diseases. Available at https://www.healthline.com/health/non-communicable-diseases-list. Accessed on 12 May, 2022.

Kim, D. S., Kim, Y., Jeon, J. Y., & Kim, M. G. (2016). Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers. Journal of ginseng research, 40(4), 375–381.

Lobay D. (2015). Rauwolfia in the Treatment of Hypertension. Integrative medicine (Encinitas, Calif.), 14(3), 40–46.

Mikaili, P., Maadirad, S., Moloudizargari, M., Aghajanshakeri, S., & Sarahroodi, S. (2013). Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iranian journal of basic medical sciences, 16(10), 1031–1048.

Mishra, S., Aeri, V., Gaur, P. K., & Jachak, S. M. (2014). Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed research international, 2014, 808302.

Mitra M, Gantait S, Mandal N. (2020). Coleus forskohlii: advancements and prospects of in vitro biotechnology. Appl Microbiol Biotechnol. Mar; 104 (6):2359-2371.

Modu S. Adeboye A.E, Maisaratu A. and Mubi B.M (2013). Studies on the administration of Vernoniaamygdalina Del. (Bitter leaf) and Glucophage on blood glucose level of alloxan-induced diabetic rats. International journal of medicinal plant and alternative medicine; 1(1), 13–19.

Moradi, M. T., Rafieian-Koupaei, M., Imani-Rastabi, R., Nasiri, J., Shahrani, M., Rabiei, Z., & Alibabaei, Z. (2013). Antispasmodic effects of yarrow (Achillea millefolium L.) extract in the isolated ileum of a rat. African journal of traditional, complementary, and alternative medicines: AJTCAM, 10(6), 499–503.

Prakash OM, Rajesh K, Ritika S, Pragya T, Shradha M, Ajeet O, (2015). Plants explored with antidiabetic properties: A review. American Journal of Pharmacological Sciences, 3(3), 55-66.

Omeje EO, Khan MP, Osadebe PO, Tewari D, Khan MF, Dev K, Maurya R, Chattopadhyay N. (2014). Analysis of constituents of the eastern Nigeria mistletoe, Loranthus micranthus linn revealed the presence of new classes of osteogenic compounds. J Ethnopharmacol, 151 (1), 643-51.

Omoirri M. A. O., Odigie M., Gbagbeke K. O., Ajegi I. F., Oseyomon J. O., Okafoanyali O. J., and Eje V. I., (2018). A Review on Ethnopharmacology of Antidiabetic Plants. Asian Plant Research Journal, 1(1), 42841.

Ozougwu J. C. (2017). Nigerian Medicinal Plants with Anti-Diabetic and Anti-Hypertensive Properties. European Journal of Medicinal Plants, 21(3), 1-9.

Pransanna Kumar K and Ravi TegaMandapaka (2013), Effect of Moringa oleifera on blood glucose, LDL levels in type II diabetic obese people. Innovative Journal of Medical and Health Science; 3(1), 23–25.

WHO (2013). Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva: World Health Organization.

WHO (2021). Noncommunicable-diseases. Geneva: World Health Organization.

Worldometers.info. (2017) Worldometers live counters (based on information from the United Nations document “World population prospects: the 2017 revision”).